Tetrahydrocannabinolic acid is a potent PPARγ agonist with neuroprotective activity. 16 Jul Continue reading →
The endocannabinoid system as a target for the treatment of motor dysfunction. 28 May Continue reading →
Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington’s disease Continue reading →